Action Bait

Home for All Your Fishing Equipment Needs

Chart Nip

Price Adjustment of 14 Kinds of National Immunization Program (NIP) Vaccines in China

www.shcri.com -- At the end of July of 2009, the National Development & Reform Commission of China issued the “General Office of the National Development & Reform Commission’s Notification on the Price Adjustment of Recombinant Hepatitis B Vaccine and Other 13 Kinds of NIP Vaccines”. According to the notification, 14 kinds of NIP vaccines’ prices will have a varying degree of adjustments, including “Recombinant Hepatitis B Vaccine”, “Live Attenuated Polio Vaccine Candy”, “Diphtheria, Tetanus and Pertussis Combined Vaccine, Adsorbed”, “Live Attenuated Measles Vaccine”, “Measles Mumps and Rubella Vaccine Live” and “Japanese Encephalitis Vaccine, Live”.

 

Chart Cost Prices of 14 Kinds of NIP Vaccines (tax included)

Serial Number

Adopted Drug Name

Medicament Form

Single-dose Dosage

Cost Price (Unit in USD)

 

1

Recombinant Hepatitis B Vaccine

Liquid preparation

5ug

0.278

10ug

0.454

20ug

0.571

2

Intradermal injection of BCG

Lyophilized preparation

0.1ml

0.110

3

Live Attenuated Polio Vaccine Candy

Sugar-pill

1 pill

0.078

Live Attenuated Oral Poliomyelitis Vaccine

Liquid preparation

0.1ml

0.142

4

Diphtheria,Tetanus and AcelluIar Pertussis Combined Vaccine,Adsorbed

Liquid preparation

0.5ml

0.498

Diphtheria, Tetanus and Pertussis Combined Vaccine, Adsorbed

Liquid preparation

0.5ml

0.041

5

Diphtheria and Tetanus Combined Vaccine, Adsorbed

Liquid preparation

0.5ml

0.047

6

Live Attenuated Measles Vaccine

Lyophilized preparation

0.5ml

0.161

7

Measles Mumps and Rubella Vaccine Live

Lyophilized preparation

0.5ml

3.045

Measles and Rubella Combined Attenuated Live Vaccine, MR

Lyophilized preparation

0.5ml

0.849

Measles and Mumps Combined Vaccine,Live

Lyophilized preparation

0.5ml

0.820

8

Japanese Encephalitis Vaccine,Live

Lyophilized preparation

0.5ml

1.054

 

Liquid preparation

0.5ml

0.952

 

Inactivated Japanese Encephalitis Vaccine (Inactivated JE Vaccine)

Lyophilized preparation

0.5ml

1.054

9

Group A Meningococcal Polysaccharide Vaccine

Lyophilized preparation

30ug

0.102

10

Group A & Group C Meningococcal Glycoconjugate Vaccine

Lyophilized preparation

10ug

1.537

Meningococcal Group A&C Meningococcal Polysaccharide Conjugate Vaccine

Lyophilized preparation

100ug

0.512

11

Attenuated Hepatitis A Vaccine,Live

Lyophilized preparation

1ml

2.855

Inactivated Hepatitis A Vaccine  

Liquid preparation

0.5ml

4.700

12

Bivalent Purified Hemorrhagic Fever with Renal Syndrome Vaccine

Liquid preparation

1ml

1.245

13

Anthrax?Vaccine?(Live)?for?Percutaneous?Scarification

 

0.05ml

2.240

14

Leptospirosis Vaccine

Liquid preparation

0.5ml

0.073

 

In May of 2009, the National Development and Reform Commission of China held a charrette on planning the price reform of immune drugs. In July, it published the notification on declining drug prices, adjusting prices of14 kinds of immunization program vaccines.

 

Generally, high-price vaccines have a price reduction and low-price vaccines have a rising price. High-price products like Measles Mumps& Rubella Vaccine Live and Measles & Rubella Combined Vaccine (MR) have a price reduction of 35% and 47%. The prices of low-price vaccines like Live Attenuated Polio Vaccine Candy and Group A Meningococcal Polysaccharide Vaccine rise by 112% and 40% respectively.

 

The price adjustment measure will have a great impact on enterprises manufacturing a large proportion of these vaccines.

 

This time, the National Development and Reform Commission of China adjusts prices of NIP vaccines in the situation of new Chinese medical reform. By administrative means, the government reduces profits of pharmaceutical producing enterprises, as well as the costs that are used by the government to improve the public health service.

 

Chinese government might enlarge the scope to reduce prices of government purchasing drugs. After all, in the current industrial environment, the government bears some pressure on paying for the medical reform. Transferring partial reform costs to manufacture enterprises might be a choice for the government. In the future, prices of medical products with high homogenization and low added values are expected to be reduced more obviously. A new round of drug price cuts based on the survey of drug costs will come.

 

Source: China Research and Intelligence

If you'd like to copy or quote this article, please keep the source information

 

More information can be browsed:

http://www.shcri.com/reportdetail.asp?id=218

About the Author

Based on the database, Interviews and research methods from China Research and Intelligence, CRI analyzes the development and opportunities in this industry clearly.
Contacts:
Eileen Gu
China Research and Intelligence
www.shcri.com
Email: eileen@shcri.com
TEL: 86-21-6852-1029
86-21-5842-6733